Abstract
Park et al report in this issue of Blood that, despite the results reported in major clinical trials, the rate of early death (ED) in acute promyelocytic leukemia (APL) found in a population-based study remains high over the past 15 years.
Original language | English |
---|---|
Pages (from-to) | 1188-1189 |
Number of pages | 2 |
Journal | Blood |
Volume | 118 |
Issue number | 5 |
DOIs | |
Publication status | Published - Aug 4 2011 |
ASJC Scopus subject areas
- Hematology
- Biochemistry
- Cell Biology
- Immunology